6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine
C19H23N5 — CID 110117694
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine
6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine (PubChem CID 110117694) has the molecular formula C19H23N5 and a molecular weight of 321.43 g/mol. Its IUPAC name is 6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine.
Molecular Properties
| Compound Name | 6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine |
|---|---|
| PubChem CID | 110117694 |
| Molecular Formula | C19H23N5 |
| Molecular Weight | 321.43 g/mol |
| Exact Mass | 321.20 |
| IUPAC Name | 6-phenyl-7-[(2-propan-2-ylpyrazol-3-yl)methyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine |
| SMILES | CC(C)n1nccc1CN1Cc2nccn2CC1c1ccccc1 |
| InChI | InChI=1S/C19H23N5/c1-15(2)24-17(8-9-21-24)12-23-14-19-20-10-11-22(19)13-18(23)16-6-4-3-5-7-16/h3-11,15,18H,12-14H2,1-2H3 |
| InChIKey | LTHQDRPIVGLGIT-UHFFFAOYSA-N |
| XLogP | 3.42 |
| TPSA | 38.88 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 321.43 |
| LogP ≤ 5 | 3.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 110117694 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.